IRX4 at 5p15 suppresses prostate cancer growth through the interaction with vitamin D receptor, conferring prostate cancer susceptibility

Human Molecular Genetics

Volumn 21, Issue 9, 2012, Pages 2076-2085

  Nguyen, Hai Ha ^a   Takata, Ryo ^a,b   Akamatsu, Shusuke ^a,c   Shigemizu, Daichi ^d   Tsunoda, Tatsuhiko ^d   Furihata, Mutsuo ^d   Takahashi, Atsushi ^a   Kubo, Michiaki ^a   Kamatani, Naoyuki ^a   Ogawa, Osamu ^c   Fujioka, Tomoaki ^b   Nakamura, Yusuke ^e   Nakagawa, Hidewaki ^a  

^a RIKEN   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d KOCHI MEDICAL SCHOOL   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; IROQUOIS HOMEOBOX 4; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CHROMOSOME 5P; GENE OVEREXPRESSION; GENOTYPE; HEART; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; TRANSCRIPTION REGULATION;

5' UNTRANSLATED REGIONS; BASE SEQUENCE; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 5; CLONING, MOLECULAR; EXONS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HOMEODOMAIN PROTEINS; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, CALCITRIOL; RNA, SMALL INTERFERING;

EID: 84859227397     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds025     Document Type: Article

References (31)

1. Gronberg, H. (2003) Prostate cancer epidemiology. Lancet, 361, 859-864.
2. Schaid, D.J. (2004) The complex genetic epidemiology of prostate cancer. Hum. Mol. Genet., 13, R103-R121.
3. Lichtenstein, P., Holm, N., Verkasalo, P., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A. and Hemminki, K. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med., 343, 78-85.
4. Gudmundsson, J., Sulem, P., Manolescu, A., Amundadottir, L.T., Gudbjartsson, D., Helgason, A., Rafnar, T., Bergthorsson, J.T., Agnarsson, B.A., Baker, A. et al. (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet., 39, 631-637.
5. Yeager, M., Orr, N., Hayes, R.B., Jacobs, K.B., Kraft, P., Wacholder, S., Minichiello, M.J., Fearnhead, P., Yu, K., Chatterjee, N. et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet., 39, 645-649.
6. Gudmundsson, J., Sulem, P., Rafnar, T., Bergthorsson, J.T., Manolescu, A., Gudbjartsson, D., Agnarsson, B.A., Sigurdsson, A., Benediktsdottir, K.R., Blondal, T. et al. (2008) Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat. Genet., 40, 281-283.
7. Eeles, R.A., Kote-Jarai, Z., Giles, G.G., Olama, A.A., Guy, M., Jugurnauth, S.K., Mulholland, S., Leongamornlert, D.A., Edwards, S.M., Morrison, J. et al. (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet., 40, 316-321.
8. Thomas, G., Jacobs, K.B., Yeager, M., Kraft, P., Wacholder, S., Orr, N., Yu, K., Chatterjee, N., Welch, R., Hutchinson, A. et al. (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat. Genet., 40, 310-315.
9. Gudmundsson, J., Sulem, P., Gudbjartsson, D.F., Blondal, T., Gylfason, A., Agnarsson, B.A., Benediktsdottir, K.R., Magnusdottir, D.N., Orlygsdottir, G., Jakobsdottir, M. et al. (2009) Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat. Genet., 41, 1022-1026.
10. Takata, R., Akamatsu, S., Kubo, M., Takahashi, A., Hosono, N., Kawaguchi, T., Tsunoda, T., Inazawa, J., Kamatani, N., Ogawa, O. et al. (2010) Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nat. Genet., 42, 751-754.
11. Kote-Jarai, Z., Al Olama, A.A., Giles, G.G., Severi, G., Schleutker, J., Weischer, M., Campa, D., Riboli, E., Key, T., Gronberg, H. et al. (2011) Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat. Genet., 43, 785-789.
12. Haiman, C.A., Chen, G.K., Blot, W.J., Strom, S.S., Berndt, S.I., Kittles, R.A., Rybicki, B.A., Isaacs, W.B., Ingles, S.A., Stanford, J.L. et al. (2011) Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat. Genet., 43, 570-573.
13. Chang, B., Cramer, S., Wiklund, F., Isaacs, S., Stevens, V., Sun, J., Smith, S., Pruett, K., Romero, L., Wiley, K. et al. (2009) Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. Hum. Mol. Genet., 18, 1368-1375.
14. Ahmadiyeh, N., Pomerantz, M.M., Grisanzio, C., Herman, P., Jia, L., Almendro, V., He, H.H., Brown, M., Liu, S., Davis, M. et al. (2007) 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc. Natl Acad. Sci. USA, 107, 9742-9746.
15. Akamatsu, S., Takata, R., Ashikawa, K., Hosono, N., Kamatani, N., Fujioka, T., Ogawa, O., Kubo, M., Nakamura, Y. and Nakagawa, H. (2010) A functional variant in NKX3.1 associated with prostate cancer susceptibility down-regulates NKX3.1 expression. Hum. Mol. Genet., 19, 4265-4272.
16. Bao, Z.Z., Bruneau, B.G., Seidman, J.G., Christine, E., Seidman, C.E. and Cepko, C.L. (1999) Regulation of chamber-specific gene expression in the developing heart by Irx4. Science, 283, 1161-1164.
17. Bruneau, B.G., Bao, Z.Z., Tanaka, M., Schott, J.J., Izumo, S., Cepko, C.L., Seidman, J.G. and Seidman, C.E. (2000) Cardiac expression of the ventricle-specific homeobox gene Irx4 is modulated by Nkx2-5 and dHand. Dev. Biol., 217, 266-277.
18. Bruneau, B.G., Bao, Z.Z., Fatkin, D., Xavier-Neto, J., Georgakopoulos, D., Maguire, C.T., Berul, C.I., Kass, D.A., Kuroski-de Bold, M.L., de Bold, A.J. et al. (2001) Cardiomyopathy in Irx4-deficient mice is preceded by abnormal ventricular gene expression. Mol. Cell Biol., 21, 1730-1736.
19. Ilić, M., Vlajinac, H. and Marinković, J. (1996) Case-control study of risk factors for prostate cancer. Br. J. Cancer, 74, 1682-1686.
20. Wang, G.F., Nikovits, W.J., Bao, Z.Z. and Stockdale, F.E. (2001) Irx4 forms an inhibitory complex with the vitamin D and retinoic X receptors to regulate cardiac chamber-specific slow MyHC3 expression. J. Biol. Chem., 276, 28835-28841.
21. Guo, X., Liu, W., Pan, Y., Ni, P., Ji, J., Guo, L., Zhang, J., Wu, J., Jiang, J., Chen, X. et al. (2010) Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma. Oncogene, 29, 3908-3920.
22. Zhao, H., Kim, Y., Wang, P., Lapointe, J., Tibshirani, R., Pollack, J.R. and Brooks, J.D. (2005) Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines. Prostate, 63, 187-197.
23. Myrthue, A., Rademacher, B.L., Pittsenbarger, J., Kutyba-Brooks, B., Gantner, M., Qian, D.Z. and Beer, T.M. (2008) The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells. Clin. Cancer Res., 14, 3562-3570.
24. Jian, Z., Wang, Z., Kunej, T., Williams, G.A., Michal, J.J., Wu, X-L. and Magnuson, N.S. (2007) A novel type of sequence variation: multiple-nucleotide length polymorphisms discovered in the bovine genome. Genetics, 176, 403-407.
25. Chung, S., Nakagawa, H., Uemura, M., Piao, L., Ashikawa, K., Hosono, N., Takata, R., Akamatsu, S., Kawaguchi, T., Morizono, T. et al. (2011) Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci., 102, 245-252.
26. Heinemeyer, T., Wingender, E., Reuter, I., Hermjakob, H., Kel, A., Kel, O., Ignatieva, E., Ananko, E., Podkolodnaya, O., Kolpakov, F. et al. (1998) Databases on transcription regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res., 26, 362-367.
27. Pomerantz, M.M., Ahmadiyeh, N., Jia, L., Herman, P., Verzi, M.P., Doddapaneni, H., Beckwith, C.A., Chan, J.A., Hills, A., Davis, M. et al. (2009) The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat. Genet., 41, 882-884.
28. Macias-Gonzalez, M. and Carlberg, C. (2002) Cross-repression, a functional consequence of the physical interaction of non-liganded nuclear receptors and POU domain transcription factors. J. Biol. Chem., 277, 18501-18509.
29. Seoane, S., Ben, I., Centeno, V. and Perez-Fernandez, R. (2007) Cellular expression levels of the vitamin D receptor are critical to its transcriptional regulation by the pituitary transcription factor Pit-1. Mol. Endocrinol., 21, 1513-1525.
30. Seoane, S. and Perez-Fernandez, R. (2006) The vitamin D receptor represses transcription of the pituitary transcription factor Pit-1 gene without Involvement of the retinoid X receptor. Mol. Endocrinol., 20, 735-748.
31. Ohnishi, Y., Tanaka, T., Ozaki, K., Yamada, R., Suzuki, H. and Nakamuara, Y. (2001) A high-throughput SNP typing system for genome-wide association studies. J. Hum. Genet., 46, 471-477.